Dr. Asma Al Olama
President, Emirates Society of Haematology
Consultant Hematologist
Dubai Hospital, United Arab Emirates
CME Accredited
Endorsed by ESH
Cure Series
CAR T Updates and
Real World Exchange
A structured, phased scientific exchange forum designed to support evidence based clinical practice in CAR T therapy for patients with 2L+ DLBCL.
- Date
- 30th June 2026
- Time and Format
- 08:00 PM GMT +4 (UAE Time) · Virtual
Event starts in
00
Days
00
Hours
00
Minutes
00
Seconds
30th June 2026 · 08:00 PM GMT +4 (UAE Time)
3
Expert Faculty
5
Live Sessions
2 Hours
Live and Interactive
CME
Accredited
Why attend
Join the conversation
A structured, phased scientific exchange forum designed to support evidence based clinical practice in CAR T therapy for patients with 2L+ DLBCL. Hear from leading haematology faculty and take part in a focused panel discussion.
Evidence based
Grounded in current clinical data for 2L+ DLBCL.
Real world exchange
Practical insight from practising haematologists.
Interactive
Live panel discussion and audience Q and A.
Meet the experts
Faculty
Dr. Hassan Ghazal
Consultant Medical Oncologist
Consultant Clinical Haematologist
Al Zahra Hospital, United Arab Emirates
Dr. Rahuman Salim
Consultant Haematologist
American Hospital, United Arab Emirates
Programme
Agenda
30th June 2026 · 08:00 PM GMT +4 (UAE Time) · Virtual
-
8:00 to 8:05 PM
Welcome and Introduction
Dr. Asma Al Olama
-
8:05 to 8:50 PM
Who is CAR T eligible?
Dr. Rahuman Salim
-
8:50 to 9:35 PM
Can CAR T achieve CURE for 2L+ DLBCL?
Dr. Hassan Ghazal
-
9:35 to 9:50 PM
Panel Discussion and Q&A
All faculty
-
9:50 to 10:00 PM
Closing
Dr. Asma Al Olama
Reserve your place
Registration is quick and free. Secure your seat at the Cure CAR T virtual session and receive joining details by email.
- CME accredited
- Live faculty panel
- No cost to attend
Endorsed by
Supported by
Powered by
